Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.
2.

Quinazolines and 1,4-benzodiazepines. 92. Conformational recognition of the receptor by 1,4-benzodiazepines.

Blount JF, Fryer RI, Gilman NW, Todaro LJ.

Mol Pharmacol. 1983 Nov;24(3):425-8.

PMID:
6314115
3.
5.

Structure-activity studies of beta-carboline analogs.

Lawson JA, Uyeno ET, Nienow J, Loew GH, Toll L.

Life Sci. 1984 May 21;34(21):2007-13.

PMID:
6328151
6.

The nature of 1,4-benzodiazepines/receptor interactions.

Borea PA, Gilli G.

Arzneimittelforschung. 1984;34(6):649-52.

PMID:
6091702
7.

Biomimetic approach to potential benzodiazepine receptor agonists and antagonists.

Guzman F, Cain M, Larscheid P, Hagen T, Cook JM, Schweri M, Skolnick P, Paul SM.

J Med Chem. 1984 May;27(5):564-70.

PMID:
6325688
8.

Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors.

Wong G, Koehler KF, Skolnick P, Gu ZQ, Ananthan S, Schönholzer P, Hunkeler W, Zhang W, Cook JM.

J Med Chem. 1993 Jun 25;36(13):1820-30.

PMID:
8390574
9.

Torsionally and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands.

Anstead GM, Peterson CS, Pinney KG, Wilson SR, Katzenellenbogen JA.

J Med Chem. 1990 Oct;33(10):2726-34.

PMID:
2213825
10.

Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.

Frølund B, Jensen LS, Guandalini L, Canillo C, Vestergaard HT, Kristiansen U, Nielsen B, Stensbøl TB, Madsen C, Krogsgaard-Larsen P, Liljefors T.

J Med Chem. 2005 Jan 27;48(2):427-39.

PMID:
15658856
11.

Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines.

Watjen F, Baker R, Engelstoff M, Herbert R, MacLeod A, Knight A, Merchant K, Moseley J, Saunders J, Swain CJ, et al.

J Med Chem. 1989 Oct;32(10):2282-91.

PMID:
2552115
12.

Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.

van Muijlwijk-Koezen JE, Timmerman H, Vollinga RC, Frijtag von Drabbe Künzel J, de Groote M, Visser S, IJzerman AP.

J Med Chem. 2001 Mar 1;44(5):749-62.

PMID:
11262085
13.

Effects of addition of a 2-methyl group to ethyl nipecotates (beta-meperidines) on receptor affinities and opiate agonist/antagonist activities.

Lawson JA, Cheng A, DeGraw J, Frenking G, Uyeno E, Toll L, Loew GH.

J Med Chem. 1988 Oct;31(10):2015-21.

PMID:
2845084
14.
16.

Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands.

Borea PA, Gilli G, Bertolasi V, Ferretti V.

Mol Pharmacol. 1987 Apr;31(4):334-44.

PMID:
3033465
17.

Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABA(A) receptor complex.

Marder M, Estiú G, Blanch LB, Viola H, Wasowski C, Medina JH, Paladini AC.

Bioorg Med Chem. 2001 Feb;9(2):323-35.

PMID:
11249125
18.

Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.

Duax WL, Swenson DC, Strong PD, Korach KS, McLachlan J, Metzler M.

Mol Pharmacol. 1984 Nov;26(3):520-5.

PMID:
6548545
19.

Molecular determinants of mu receptor recognition for the fentanyl class of compounds.

Cometta-Morini C, Maguire PA, Loew GH.

Mol Pharmacol. 1992 Jan;41(1):185-96.

PMID:
1310142
20.

Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists.

Keenan RM, Callahan JF, Samanen JM, Bondinell WE, Calvo RR, Chen L, DeBrosse C, Eggleston DS, Haltiwanger RC, Hwang SM, Jakas DR, Ku TW, Miller WH, Newlander KA, Nichols A, Parker MF, Southhall LS, Uzinskas I, Vasko-Moser JA, Venslavsky JW, Wong AS, Huffman WF.

J Med Chem. 1999 Feb 25;42(4):545-59.

PMID:
10052962

Supplemental Content

Support Center